The Menopause Treatment Market is projected to reach $3.3BN by 2023, posting 4.2% CAGR from 2017 to 2023, according to MRFR. Destigmatizing menopause and capturing this opportunity has gone beyond indie trailblazers like Pause. There’s a new player in the burgeoning menopause category, launched by P&G Ventures and venture engine M13. Kindra is a direct-to-consumer brand that takes a candid approach, providing proven, estrogen-free solutions, a supportive community, and personalized resources for women managing menopause and looking to relieve symptoms.

“Half the people on the planet experience menopause, yet even in our age of oversharing, it, unfortunately, remains a taboo topic with a limited range of products, resources and emotional support available to women experiencing this journey,” HongJoo Sun, CEOat Kindra, said in a statement. “With Kindra we’re looking to provide women with clinically proven symptom relief and support while also sparking a more open conversation on the challenges and triumphs of a life stage every woman will expect to experience.”

Kindra is the first brand launched by M13’s Launchpad, its venture studio that accelerates brands into sustainable businesses with partners such as P&G Ventures. Kindra’s founding team leveraged P&G Ventures’ strengths in new brand creation, innovation, and scale with M13’s entrepreneurial talent and agility, DTC capabilities, and network of investors and advisors. The company is led by co-founders HongJoo Sun (CEO), Whitney Gosden (Head of Marketing), and Austin Deng (Head of Product), and absorbs existing P&G Ventures menopause brand Pepper&Wits.

The post Kindra: The New P&G-Backed DTC Player in the Menopause Category appeared first on BeautyMatter.

This content was originally published here.